A recent study validated earlier findings that methylation was correlated with the expression of the HLA-DRB1*1501 allele [34], and highlighted that methylation alone, apart from the MHC II region, was a stronger discriminator of MS than previously described known genetic risk factors [35]. Here, HLA-DRB1 is linked to myeloid sarcoma.